Walleye Trading’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Walleye Trading’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-62,928	Closed	-$647K	–	5481
2023 Q1	$647K	Sell	62,928 -72	-0.1%	-$739	﹤0.01%	2581
2022 Q4	$648K	Hold	63,000	–	–	﹤0.01%	2603
2022 Q3	$634K	Hold	63,000	–	–	﹤0.01%	2678
2022 Q2	$631K	Hold	63,000	–	–	﹤0.01%	2674
2022 Q1	$630K	Buy	+63,000	New	+$626K	﹤0.01%	2677

Walleye Trading's IQMD Position: Q2 2023 in Review

Walleye Trading sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q2 2023, closing a stake of 62,928 shares — an estimated $647K sold.

Walleye Trading first reported a position in IQMD in Q1 2022 and held it in 5 quarters. The position peaked at $648K in Q4 2022. 0 funds tracked by Wall St. Rank hold IQMD as of Q2 2023.

Walleye Trading reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Walleye Trading sold 62,928 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $647K.
Walleye Trading first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
Walleye Trading's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $648K in Q4 2022.
0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.